Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 EUR | +3.10% | +1.01% | -10.21% |
2023 | Medicon Hellas S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2022 | Medicon Hellas S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 3.801 | 5.083 | 10.52 | 8.397 | 21.57 | 16.35 |
Enterprise Value (EV) 1 | 18.11 | 13.15 | 19.23 | 14.51 | 23.32 | 17.17 |
P/E ratio | 2.21 x | 2.78 x | 13.6 x | 11.1 x | 7.09 x | 6.46 x |
Yield | - | - | - | - | - | 4.14% |
Capitalization / Revenue | 0.3 x | 0.37 x | 0.78 x | 0.55 x | 1 x | 0.79 x |
EV / Revenue | 1.43 x | 0.95 x | 1.43 x | 0.95 x | 1.08 x | 0.83 x |
EV / EBITDA | 7 x | 4.58 x | 10 x | 5.86 x | 3.8 x | 3.37 x |
EV / FCF | 8.45 x | 4.24 x | 217 x | 4.9 x | 5.03 x | 15.1 x |
FCF Yield | 11.8% | 23.6% | 0.46% | 20.4% | 19.9% | 6.62% |
Price to Book | 0.48 x | 0.53 x | 1.03 x | 0.76 x | 1.5 x | 0.96 x |
Nbr of stocks (in thousands) | 4,420 | 4,420 | 4,420 | 4,420 | 4,420 | 4,420 |
Reference price 2 | 0.8600 | 1.150 | 2.380 | 1.900 | 4.880 | 3.700 |
Announcement Date | 18-04-23 | 19-04-18 | 20-06-19 | 21-04-26 | 22-04-29 | 23-04-27 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 12.7 | 13.77 | 13.45 | 15.27 | 21.51 | 20.77 |
EBITDA 1 | 2.588 | 2.874 | 1.919 | 2.475 | 6.13 | 5.094 |
EBIT 1 | 1.941 | 2.251 | 1.1 | 1.58 | 4.985 | 3.847 |
Operating Margin | 15.28% | 16.34% | 8.18% | 10.35% | 23.18% | 18.52% |
Earnings before Tax (EBT) 1 | 2.301 | 3.601 | 1.528 | 1.452 | 4.778 | 3.655 |
Net income 1 | 1.718 | 1.83 | 0.7752 | 0.7566 | 3.04 | 2.533 |
Net margin | 13.52% | 13.29% | 5.76% | 4.96% | 14.14% | 12.2% |
EPS 2 | 0.3887 | 0.4141 | 0.1754 | 0.1712 | 0.6879 | 0.5732 |
Free Cash Flow 1 | 2.144 | 3.105 | 0.0885 | 2.964 | 4.635 | 1.137 |
FCF margin | 16.88% | 22.55% | 0.66% | 19.42% | 21.55% | 5.47% |
FCF Conversion (EBITDA) | 82.83% | 108.04% | 4.61% | 119.74% | 75.61% | 22.31% |
FCF Conversion (Net income) | 124.81% | 169.63% | 11.41% | 391.77% | 152.45% | 44.87% |
Dividend per Share | - | - | - | - | - | 0.1531 |
Announcement Date | 18-04-23 | 19-04-18 | 20-06-19 | 21-04-26 | 22-04-29 | 23-04-27 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 14.3 | 8.07 | 8.71 | 6.11 | 1.75 | 0.82 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 5.529 x | 2.807 x | 4.539 x | 2.469 x | 0.2859 x | 0.1601 x |
Free Cash Flow 1 | 2.14 | 3.1 | 0.09 | 2.96 | 4.64 | 1.14 |
ROE (net income / shareholders' equity) | 23.5% | 20.5% | 8.03% | 7.25% | 24.1% | 16.6% |
ROA (Net income/ Total Assets) | 3.81% | 4.86% | 2.47% | 3.46% | 10.4% | 7.63% |
Assets 1 | 45.09 | 37.65 | 31.42 | 21.89 | 29.14 | 33.19 |
Book Value Per Share 2 | 1.770 | 2.190 | 2.320 | 2.500 | 3.250 | 3.840 |
Cash Flow per Share 2 | 1.000 | 1.410 | 1.370 | 1.630 | 2.340 | 2.310 |
Capex 1 | 0.13 | 0.6 | 1.89 | 0.73 | 0.55 | 0.41 |
Capex / Sales | 1.06% | 4.35% | 14.02% | 4.81% | 2.58% | 1.96% |
Announcement Date | 18-04-23 | 19-04-18 | 20-06-19 | 21-04-26 | 22-04-29 | 23-04-27 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-10.21% | 13.93M | |
+12.15% | 228B | |
+14.90% | 196B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 65.88B | |
+16.92% | 54.3B | |
+6.33% | 52.39B | |
+10.93% | 45.22B | |
+5.87% | 37.12B |
- Stock Market
- Equities
- MEDIC Stock
- Financials Medicon Hellas S.A.